Log in

Relevant bibliographies by topics / Arthritis Prognosis / Journal articles

Journal articles on the topic 'Arthritis Prognosis'

To see the other types of publications on this topic, follow the link: Arthritis Prognosis.

Author: Grafiati

Published: 10 December 2022

Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Arthritis Prognosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

ODEWUSI, OO, MJ ABDULMUMIN, and OO OLANIYAN. "AN ASSESSMENT OF AUTOIMMUNITY IN ARTHRITIS PATIENTS." International Journal of Medical Laboratory Research 07, no. 01 (2022): 53–61. http://dx.doi.org/10.35503/ijmlr.2022.7108.

Full text

Abstract:

Objectives: The goal of this study is to estimate autoimmune biomarkers that characterize the development and severity of arthritis, but probably normalize following successful therapy. Materials and methods: In this study a total of 109 subjects were used out of which treated and untreated arthritics were 48 and 44 respectively, the remaining 17 were healthy individuals which were used as control. Samples were collected from patients attending Rheumatology and Orthopedic clinic of Federal Teaching Hospital Ido-ekiti, Ekiti State Nigeria. Antinuclear antibody was estimated using Enzyme Linked Immunosorbent Assay (ELISA) while Lupus Erythematosus cells were ascertained microscopically using Leishman staining technique. All parameters were assessed in treated and untreated arthritic patients relative to healthy subjects. Body mass index was also calculated. Statistical analysis was done using SPSS. Results: Body mass index and Antinuclear antibodies were significantly higher in treated and untreated arthritics compared to control (P<0.05). When treated and untreated arthritics were compared, Body mass index and Antinuclear antibody were found to be significantly higher in untreated arthritics (P<0.05). Antinuclear antibody and Age correlated directly in untreated arthritics. Lupus Erythematosus cell prevalence was found to be higher in untreated arthritics having a percentage Lupus Erythematosus test positivity of 6.8% compared to the 2.1% seen in treated arthritics. Conclusion: It was found that Autoimmunity in arthritics can be significantly lowered through treatment with Arthritic drugs, diets, life style modifications over a period of time. The study suggests that Antinuclear antibody and Lupus Erythematosus estimations could be adopted as markers of diagnosis, prognosis and monitoring of arthritis.

APA, Harvard, Vancouver, ISO, and other styles

2

Weisman, Michael H. "Prognosis in rheumatoid arthritis." Current Opinion in Rheumatology 2, no. 3 (June 1990): 458–62. http://dx.doi.org/10.1097/00002281-199002030-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

WORCESTER, SHARON. "Childhood Arthritis Prevalence, Prognosis Eyed." Pediatric News 41, no. 6 (June 2007): 36. http://dx.doi.org/10.1016/s0031-398x(07)70386-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

MAHONEY, DIANA. "Lyme Arthritis: Accurate Dx Improves Prognosis." Family Practice News 41, no. 5 (March 2011): 38–39. http://dx.doi.org/10.1016/s0300-7073(11)70253-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Druce, Katie L., and Neil Basu. "Predictors of fatigue in rheumatoid arthritis." Rheumatology 58, Supplement_5 (November 1, 2019): v29—v34. http://dx.doi.org/10.1093/rheumatology/kez346.

Full text

Abstract:

Abstract People with RA commonly experience fatigue. Fatigue is a key contributor to increased clinical care costs, primary care consultations and employment loss. Despite this, our understanding of the prognostic of factors of poor fatigue outcomes is lacking and fatigue is poorly managed. Examining longitudinal predictors of fatigue can identify both individuals ‘at risk’ of poor prognosis, and candidate mechanisms that are worthy of greater inspection. This review discusses the factors most commonly investigated as being implicated in the prognosis of RA fatigue. The available data appears to implicate generic factors such as pain, mental health, disability and sleep as consistent predictors of fatigue outcome, while the role of disease activity and inflammation seems less clear. However, the existing data are not without methodological limitations and there have been no specific studies primarily designed to investigate the inflammatory biomarkers of fatigue. Future studies are required to more comprehensively and robustly determine the mechanisms of fatigue.

APA, Harvard, Vancouver, ISO, and other styles

6

Cho, Byung-Ki, and Seung-myung Choi. "Prognosis of Medial Gutter Osteoarthritis Combined with Chronic Ankle Instability." Foot & Ankle Orthopaedics 3, no. 3 (July 1, 2018): 2473011418S0018. http://dx.doi.org/10.1177/2473011418s00189.

Full text

Abstract:

Category: Ankle Arthritis Introduction/Purpose: Although the frequent intraarticular pathologies associated with recurrent ankle sprains are well known, informations regarding treatment method for arthritic changes in the medial gutter are still insufficient. This study was performed to evaluate the intermediate-term clinical and radiological outcomes following modified Broström procedure and arthroscopic debridement in the middle-aged patients. Methods: Twenty-two patients with medial gutter osteoarthritis related to chronic lateral ankle instability were followed for more than 3 years after surgical treatment. All patients showed medial joint space narrowing of Takakura stage 2. The clinical evaluation consisted of the American Orthopaedic Foot and Ankle Society (AOFAS) score, visual analogue scale (VAS) for medial ankle pain during walking, and Foot and Ankle Ability Measure (FAAM). Results: Mean AOFAS and FAAM scores significantly improved from 51.2 and 45.7 points preoperatively to 80.3 and 78.4 points at final followup, respectively (P < .001). Although mean pain-VAS significantly improved from 6.8 points to 3.5 points (P < .001), 8 patients (36.4%) complained of discomfort at gait with considerable pain ≥ 4 points. There was only 1 patient (4.5%) with recurrent ankle instability, while 6 patients (27.3%) showed a progression in arthritis stage. Conclusion: Modified Broström procedure concomitant with arthroscopic debridement for medial gutter osteoarthritis secondary to chronic ankle instability is not effective enough to treat the medial ankle pain and functional impairment. Alternative treatment strategies for middle-aged cohort with arthritic changes are needed to improve the clinical outcomes and to prevent a progressive osteoarthritis.

APA, Harvard, Vancouver, ISO, and other styles

7

Dakin, Stephanie G. "Synovial signatures signpost arthritis." Science Translational Medicine 11, no. 488 (April 17, 2019): eaax1725. http://dx.doi.org/10.1126/scitranslmed.aax1725.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Rasker, J. J., and J. A. Cosh. "Course and Prognosis of Early Rheumatoid Arthritis." Scandinavian Journal of Rheumatology 18, sup79 (January 1989): 45–56. http://dx.doi.org/10.3109/03009748909092612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Paroli, M. P., S. Speranza, M. Marino, M. P. Pirraglia, and P. Pivetti-Pezzi. "Prognosis of Juvenile Rheumatoid Arthritis-Associated Uveitis." European Journal of Ophthalmology 13, no. 7 (August 2003): 616–21. http://dx.doi.org/10.1177/112067210301300704.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

DE CUNTO, CARMEN L., EDWARD H. GIANNINI, CHESTER W. FINK, EARL J. BREWER, and DONALD A. PERSON. "Prognosis of children with poststreptococcal reactive arthritis." Pediatric Infectious Disease Journal 7, no. 10 (October 1988): 683–85. http://dx.doi.org/10.1097/00006454-198810000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Leirisalo-Repo, M., P. Helenius, T. Hannu, A. Lehtinen, J. Kreula, M. Taavitsainen, and S. Koskimies. "Long term prognosis of reactive salmonella arthritis." Annals of the Rheumatic Diseases 56, no. 9 (September 1, 1997): 516–20. http://dx.doi.org/10.1136/ard.56.9.516.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

MAHONEY, DIANA. "Accurate Diagnosis of Lyme Arthritis Improves Prognosis." Rheumatology News 10, no. 3 (March 2011): 38. http://dx.doi.org/10.1016/s1541-9800(11)70184-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Bendtsen, Preben, and Jan Olof Hörnquist. "Disease course and prognosis in rheumatoid arthritis." Scandinavian Journal of Social Medicine 24, no. 3 (September 1996): 193–98. http://dx.doi.org/10.1177/140349489602400311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Scott, David L. "The diagnosis and prognosis of early arthritis: Rationale for new prognostic criteria." Arthritis & Rheumatism 46, no. 2 (February 2002): 286–90. http://dx.doi.org/10.1002/art.10134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Shirtliff, Mark E., and Jon T. Mader. "Acute Septic Arthritis." Clinical Microbiology Reviews 15, no. 4 (October 2002): 527–44. http://dx.doi.org/10.1128/cmr.15.4.527-544.2002.

Full text

Abstract:

SUMMARY Acute septic arthritis may develop as a result of hematogenous seeding, direct introduction, or extension from a contiguous focus of infection. The pathogenesis of acute septic arthritis is multifactorial and depends on the interaction of the host immune response and the adherence factors, toxins, and immunoavoidance strategies of the invading pathogen. Neisseria gonorrhoeae and Staphylococcus aureus are used in discussing the host-pathogen interaction in the pathogenesis of acute septic arthritis. While diagnosis rests on isolation of the bacterial species from synovial fluid samples, patient history, clinical presentation, laboratory findings, and imaging studies are also important. Acute nongonococcal septic arthritis is a medical emergency that can lead to significant morbidity and mortality. Therefore, prompt recognition, rapid and aggressive antimicrobial therapy, and surgical treatment are critical to ensuring a good prognosis. Even with prompt diagnosis and treatment, high mortality and morbidity rates still occur. In contrast, gonococcal arthritis is often successfully treated with antimicrobial therapy alone and demonstrates a very low rate of complications and an excellent prognosis for full return of normal joint function. In the case of prosthetic joint infections, the hardware must be eventually removed by a two-stage revision in order to cure the infection.

APA, Harvard, Vancouver, ISO, and other styles

16

Li, S. C. "The Prognosis of Children Treated for Lyme Arthritis." AAP Grand Rounds 24, no. 2 (August 1, 2010): 18. http://dx.doi.org/10.1542/gr.24-2-18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Morgan, James G., and Wen-Shiung Chow. "Clinical features, diagnosis, and prognosis in rheumatoid arthritis." Current Opinion in Rheumatology 5, no. 2 (March 1993): 184–90. http://dx.doi.org/10.1097/00002281-199305020-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

McGonagle, Dennis, Wayne Gibbon, Philip O'Connor, Michael Green, Colin Pease, John Ridgway, and Paul Emery. "An anatomical explanation for good-prognosis rheumatoid arthritis." Lancet 353, no. 9147 (January 1999): 123–24. http://dx.doi.org/10.1016/s0140-6736(05)76160-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Chen, Celia S., Don Roberton, and Michael E. Hammerton. "Juvenile arthritis-associated uveitis: visual outcomes and prognosis." Canadian Journal of Ophthalmology 39, no. 6 (October 2004): 614–20. http://dx.doi.org/10.1016/s0008-4182(04)80026-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Bileckot, Richard Roger, Régis Christel Miakoundoba, and Fidèle Yala. "Microbiology and prognosis of septic arthritis in Brazzaville." Joint Bone Spine 73, no. 5 (October 2006): 575–76. http://dx.doi.org/10.1016/j.jbspin.2005.11.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

MOREL, J., and B. COMBE. "How to predict prognosis in early rheumatoid arthritis." Best Practice & Research Clinical Rheumatology 19, no. 1 (February 2005): 137–46. http://dx.doi.org/10.1016/j.berh.2004.08.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Lu, Haifeng, Yujun Yao, Jiezuan Yang, Hua Zhang, and Lanjuan Li. "Microbiome–miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities." Rheumatology International 41, no. 9 (April 15, 2021): 1567–75. http://dx.doi.org/10.1007/s00296-021-04798-3.

Full text

Abstract:

AbstractThe human microbiome has attracted attention for its potential utility in precision medicine. Increasingly, more researchers are recognizing changes in intestinal microbiome can upset the balance between pro- and anti-inflammatory factors of host immune system, potentially contributing to arthritis immunopathogenesis. Patients who develop rheumatoid arthritis from undifferentiated arthritis can face multiple irreversible joint lesions and even deformities. Strategies for identifying undifferentiated arthritis patients who have a tendency to develop rheumatoid arthritis and interventions to prevent rheumatoid arthritis development are urgently needed. Intestinal microbiome dysbiosis and shifts in the miRNA profile affect undifferentiated arthritis progression, and may play an important role in rheumatoid arthritis pathophysiologic process via stimulating inflammatory cytokines and disturbing host and microbial metabolic functions. However, a causal relationship between microbiome–miRNA interactions and rheumatoid arthritis development from undifferentiated arthritis has not been uncovered yet. Changes in the intestinal microbiome and miRNA profiles of undifferentiated arthritis patients with different disease outcomes should be studied together to uncover the role of the intestinal microbiome in rheumatoid arthritis development and to identify potential prognostic indicators of rheumatoid arthritis in undifferentiated arthritis patients. Herein, we discuss the possibility of microbiome–miRNA interactions contributing to rheumatoid arthritis development and describe the gaps in knowledge regarding their influence on undifferentiated arthritis prognosis that should be addressed by future studies.

APA, Harvard, Vancouver, ISO, and other styles

23

Stevenson, John. "Inflammatory Arthritis." InnovAiT: Education and inspiration for general practice 2, no. 10 (September 22, 2009): 585–96. http://dx.doi.org/10.1093/innovait/inp149.

Full text

Abstract:

Inflammatory arthritis is an umbrella term used to describe a range of conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and reactive arthritis. These are autoimmune diseases in which joint and systemic features are present in varying degrees between disease processes and individuals. Delayed diagnosis can lead to irreversible joint destruction and dysfunction but a therapeutic revolution has transformed its prognosis. Ever-expanding therapeutic options require GPs to recognize these conditions, manage symptoms and undertake drug monitoring. The costs to individuals, their families and the National Health Service are high. There were 1.9 million GP consultations for inflammatory arthritis in 2000 and nearly 46000 hospital admissions. The challenge in primary care is to recognize an inflammatory arthritis early and refer to secondary care.

APA, Harvard, Vancouver, ISO, and other styles

24

Özkutlu, Süheyla, Canan Ayabakan, and Muhsin Saraçlar. "Can subclinical valvitis detected by echocardiography be accepted as evidence of carditis in the diagnosis of acute rheumatic fever?" Cardiology in the Young 11, no. 3 (May 2001): 255–60. http://dx.doi.org/10.1017/s1047951101000269.

Full text

Abstract:

Aim: Subclinical valvar insufficiency, or valvitis, has recently been identified using Doppler echocardiography in cases of acute rheumatic fever with isolated arthritis or chorea. The prognosis of such patients with acute rheumatic fever and subclinical valvitis is critical when determining the duration of antibiotic prophylaxis. We aimed, therefore, prospectively to investigate the association of silent valvitis in patients having rheumatic fever in the absence of clinical evidence of cardiac involvement, and to evaluate its prognosis. Methods and Results: Between November 1998 and September 1999, we identified 26 consecutive patients with silent valvitis in presence of rheumatic fever but in the absence of clinical signs of carditis. The patients, eight female and 18 male, were aged from 6 to 16 years, with a mean of 9.9± 2.7 years. Major findings were arthritis in 16, chorea in 7, and arthritis and erythema marginatum in 1 patient. Two cases had arthralgia with equivocal arthritic signs and Doppler echocardiographic findings of pathologic mitral regurgitation. Silent pathologic mitral regurgitation was found in 12 cases, and aortic regurgitation in 2 cases. All patients with arthritic findings were treated with acetylsalicylic acid with one exception, this patient receiving both prednisone and acetylsalicylic acid. No antiinflammatory treatment was given to patients with chorea. After a mean follow-up of 4.52 months, valvar regurgitation disappeared in 4 patients, including the one with migratory arthralgia and no other major criterions. All six patients with chorea and silent carditis still have mitral insufficiency. Conclusion: Acute rheumatic fever without clinical carditis is not a benign entity. Doppler echocardiographic findings of subclinical valvar insufficiency, therefore, should be considered as carditis when seeking to establish the diagnosis of acute rheumatic fever.

APA, Harvard, Vancouver, ISO, and other styles

25

Shlopak, Lev. "Diagnosis of rheumatoid arthritis." Spravočnik vrača obŝej praktiki (Journal of Family Medicine), no. 3 (March 1, 2020): 29–36. http://dx.doi.org/10.33920/med-10-2003-03.

Full text

Abstract:

Rheumatoid arthritis is a chronic systemic autoimmune disease of the connective tissue, accompanied by a primary lesion of peripheral joints with the development of erosive-destructive changes and ankylosis. It is one of the most common chronic inflammatory diseases in humans. Early diagnosis of this pathology contributes to the timely start of therapy, which allows to reduce the level of disability and improve the prognosis for this group of patients.

APA, Harvard, Vancouver, ISO, and other styles

26

Kubanov, Alexey A., Arfenya E. Karamova, Vadim V. Chikin, Dmitry A. Verbenko, Lyudmila F. Znamenskaya, and Olga G. Artamonova. "Genetic markers for psoriatic arthritis in patients with psoriasis. Part I: non-HLA genes." Vestnik dermatologii i venerologii 97, no. 4 (October 30, 2021): 33–47. http://dx.doi.org/10.25208/vdv1260.

Full text

Abstract:

Psoriatic arthritis often develops in patients with psoriasis and can lead to joint deformity, stiffness, dysfunction, and disability. Psoriatic arthritis is a polygenic disease. and the issue of personalizing the prognosis of its development can only be resolved taking into account the variability of plenty genomic loci associated with the development of the disease. The personification of the prognosis of the disease can be solved taking into account the variability of the set of genomic loci with which its development is associated. The review examines genomic polymorphisms associated with the development of psoriatic arthritis not psoriasis, except of HLA polymorphisms. Genome regions containing polymorphisms, allelic variants of which are associated both with the development of psoriatic arthritis and reducing the likelihood of its occurrence, are described. It has been reported that the predisposition to the development of psoriatic arthritis in patients with psoriasis is determined by genes encoding proteins involved in inflammation and bone metabolism.

APA, Harvard, Vancouver, ISO, and other styles

27

Ciofoaia, Elena I., Anjani Pillarisetty, and Florina Constantinescu. "Health disparities in rheumatoid arthritis." Therapeutic Advances in Musculoskeletal Disease 14 (January 2022): 1759720X2211371. http://dx.doi.org/10.1177/1759720x221137127.

Full text

Abstract:

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation that involves symmetric polyarthritis of small and large joints. Autoimmune rheumatic diseases represent a significant socioeconomic burden as they are among the leading causes of death and morbidity due to increased risk of cardiovascular disease. Health disparities in patients with rheumatoid arthritis affect outcomes, prognosis, and management of the disease.

APA, Harvard, Vancouver, ISO, and other styles

28

Helliwell, Philip S., and Eric M. Ruderman. "Natural History, Prognosis, and Socioeconomic Aspects of Psoriatic Arthritis." Rheumatic Disease Clinics of North America 41, no. 4 (November 2015): 581–91. http://dx.doi.org/10.1016/j.rdc.2015.07.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Laasila, K. "Antibiotic treatment and long term prognosis of reactive arthritis." Annals of the Rheumatic Diseases 62, no. 7 (July 1, 2003): 655–58. http://dx.doi.org/10.1136/ard.62.7.655.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Karstila, K., M. Korpela, S. Sihvonen, H. Helin, and J. Mustonen. "Prognosis of mesangial glomerulonephritis in patients with rheumatoid arthritis." Clinical Nephrology 68, no. 11 (November 1, 2007): 335–36. http://dx.doi.org/10.5414/cnp68335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Mitchell, Donald M., Patricia W. Spitz, Donald Y. Young, Daniel A. Bloch, Dennis J. McShane, and James F. Fries. "Survival, prognosis, and causes of death in rheumatoid arthritis." Arthritis & Rheumatism 29, no. 6 (June 1986): 706–14. http://dx.doi.org/10.1002/art.1780290602.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Chiu, Ching-Ju, Yu-Ching Hsu, and Shuo-Ping Tseng. "Psychological prognosis after newly diagnosed chronic conditions: socio-demographic and clinical correlates." International Psychogeriatrics 29, no. 2 (November 2, 2016): 281–92. http://dx.doi.org/10.1017/s1041610216001630.

Full text

Abstract:

ABSTRACTBackground:This study was aimed toward discerning depressive symptom trajectories associated with different chronic conditions and toward finding modifiable factors associated with those trajectories.Methods:Data were drawn from the 1996–2007 Taiwan Longitudinal Study on Aging. Nine chronic conditions were selected, and mood trajectories were measured with the Center of Epidemiological Studies-Depression scale.Results:Among the nine chronic conditions we examined, four patterns of depressive symptom trajectories were identified: (1) elevated depressive symptoms and worsened over time after diagnosed with heart disease (n= 681), arthritis (n= 850), or hypertension (n= 1,207); (2) elevated depressive symptoms without worsening over time after diagnosed with stroke (n= 160), lung diseases (n= 432), gastric conditions (n= 691), or liver diseases (n= 234); (3) no elevated depressive symptoms after diagnosis but an increase in depressive symptoms over time for participants with diabetes (n= 499); and (4) no significant patterns after diagnosed with cancer (n= 57). Cumulative psychological burden over time was significant for participants with hypertension, diabetes, heart diseases, or arthritis. However, these effects disappeared after controlling for comorbidities and physical limitations. Moreover, psychiatric condition was found to play an important role in baseline depressive symptoms among participants diagnosed with lung diseases, arthritis, or liver diseases.Conclusions:Findings from this study provide information in addressing psychological burden at different times for different conditions. In addition, minimizing the incidence of comorbidities, physical limitations, or psychiatric conditions may have the prospective effect of avoiding the trend of increased depressive symptoms, especially when adults diagnosed with hypertension, diabetes, heart diseases, arthritis, lung diseases, arthritis, or liver diseases.

APA, Harvard, Vancouver, ISO, and other styles

33

Anghel, Daniela, Oana-Georgiana Petrache, Maria Laura Groșeanu, Maria Magdalena Negru, Cristina Florentina Pleșa, and Florentina Ioniţă Radu. "The Implication of Videocapillaroscopy in Rheumatoid Arthritis and Psoriatic Arthritis." Internal Medicine 19, no. 2 (February 1, 2022): 55–61. http://dx.doi.org/10.2478/inmed-2022-0207.

Full text

Abstract:

Abstract Videocapillaroscopy is an easy, noninvasive examination method that detects morphological microvascular abnormalities, such as nailfold capillaries. This method has a low cost, has high sensitivity and specificity, has reproductibility and the results can be easily interpreted. Besides its importance in the evaluation of Raynaud’s phenomenon and systemic sclerosis, nailfold capillaroscopy may play an important role in the diagnosis, evaluation and prognosis of other rheumatic diseases, such as rheumatoid arthritis and psoriatic arthritis. Because there are not enough data, currently, capillaroscopy is not routinely used in these patients. The aim of this review is to present the implications of the videocapillaroscopy in rheumatic diseases, other than systemic sclerosis, in order to promote this method as a routine investigation in rheumatic patients.

APA, Harvard, Vancouver, ISO, and other styles

34

Gamalero, Lisa, Giovanna Ferrara, Teresa Giani, and Rolando Cimaz. "Acute Arthritis in Children: How to Discern between Septic and Non-Septic Arthritis?" Children 8, no. 10 (October 13, 2021): 912. http://dx.doi.org/10.3390/children8100912.

Full text

Abstract:

The term septic arthritis refers to an infection of the synovial space. This is an infrequent condition in healthy children, but it should be considered a medical emergency potentially leading to irreversible articular damage. Therefore, prompt diagnosis and antimicrobial treatment play a crucial role in improving the prognosis. Although septic arthritis is the most common cause of acute arthritis, many other diseases may mimic a similar clinical picture, constituting a diagnostic challenge for the clinician who first approaches the patient. Herein we analyze the main features of septic arthritis, offering an overview of the main conditions involved in the differential diagnosis and suggesting a diagnostic workup plan.

APA, Harvard, Vancouver, ISO, and other styles

35

Dariushnejad, Hassan, Leila Chodari, Mehrnoosh Sedighi, Soheila Akbari, and Vajihe Ghorbanzadeh. "Rheumatoid arthritis: current therapeutics compendium." Endocrine Regulations 56, no. 2 (April 1, 2022): 148–62. http://dx.doi.org/10.2478/enr-2022-0016.

Full text

Abstract:

Abstract Rheumatoid arthritis is a common chronic inflammatory disease with substantial economic, social, and personal costs. Its pathogenesis is multifactorial and complex. The ultimate goal of rheumatoid arthritis treatment is stopping or slowing down the disease progression. In the past two decades, invention of new medicines, especially biologic agents, revolutionized the management of this disease. These agents have been associated with an improved prognosis and clinical remission, especially in patients who did not respond to traditional disease-modifying anti-rheumatic drugs (DMARDs). Improvement in the understanding of the rheumatoid arthritis pathogenesis leads to the development of novel biologic therapeutic approaches. In the present paper, we summarized the current therapeutics, especially biologic agents, available for the treatment of rheumatoid arthritis.

APA, Harvard, Vancouver, ISO, and other styles

36

Mendoza-Vázquez, Guadalupe, Francisco Espinoza-Gómez, Alberto Daniel Rocha-Muñoz, Jorge I. Gamez-Nava, Laura Gonzalez-Lopez, Mario Salazar-Paramo, Carlos Riebeling-Navarro, Javier Alejandro Aceves-Aceves, Sandra Guzmán-Silahua, and Arnulfo Hernán Nava-Zavala. "Correlation between percentage of fat mass and level of disease activity in rheumatoid arthritis." SAGE Open Medicine 10 (January 2022): 205031212210858. http://dx.doi.org/10.1177/20503121221085821.

Full text

Abstract:

Introduction: Controversies exist regarding the relationship between body fat and disease activity in patients with rheumatoid arthritis. The evaluation of the disease is critical for establishing treatment and prognosis. Fat mass could be a predictive factor for poor prognosis in rheumatoid arthritis because of its association with low- and high-grade inflammation. Objective: To evaluate the correlation between fat mass values and disease activity in patients with rheumatoid arthritis. Materials and methods: This was a cross-sectional study. Eighty female patients diagnosed with rheumatoid arthritis (American College of Rheumatology of 1987) were evaluated. For each one, the evaluation determined fat mass using bioelectrical impedance analysis and disease activity using the Disease Activity Score on 28 joints (DAS28). Results: The mean age was 59.11 ± 9.92 years, with an average disease duration of 14.13 ± 10.13 years; 85% of patients showed a high body fat percentage. Pearson’s correlation between DAS28 values and fat mass was r = 0.035 ( p = 0.76). Conclusion: The levels of DAS28 showed no correlation with fat mass percentage. Further studies are required to clarify the factors that can modify these levels.

APA, Harvard, Vancouver, ISO, and other styles

37

Vranis, Neil M., Bryan Marascalchi, and Eitan Melamed. "Trends in Proximal Interphalangeal and Metacarpophalangeal Joint Arthroplasty Utilization Using Statewide Databases." Journal of Hand Surgery (Asian-Pacific Volume) 25, no. 01 (January 31, 2020): 39–46. http://dx.doi.org/10.1142/s2424835520500058.

Full text

Abstract:

Background: Arthritis can have profound debilitating effects on the hand secondary to finger deformities and pain. Arthroplasty of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) can be performed to reduce pain while maintaining joint range of motion. Methods: We used outpatient surgery registries from the states of California and Florida to assess the trends of arthroplasty across several recent years and to determine if the outcomes differ based on disease etiology. Results: We found that there has been a steady decline in number of MCP arthroplasty procedures performed annually between 2005 and 2011 while PIP arthroplasty procedures peaked in 2007 and have since also declined. There was an overall complication rate of 2.4% and no difference in cardiac, respiratory, deep venous thrombosis and infection between patients with osteoarthritis and other arthritic etiologies. However, the risk of device failure in patients with rheumatoid arthritis is found to be significantly higher than for patients with osteoarthritis (p < 0.01). Conclusions: PIP and MCP arthroplasty are safe procedures with an overall low complication rate. The increased risk of device related complications observed in patients with rheumatoid arthritis can be used to appropriately counsel this patient population regarding post-operative expectations and prognosis.

APA, Harvard, Vancouver, ISO, and other styles

38

Alekseeva, Olga, Alexander Smirnov, Alexander Volkov, and Evgeniy Nasonov. "DIAGNOSIS AND PROGNOSIS OF RHEUMATOID ARTHRITIS: FOCUS ON DIAGNOSTIC METHODS." Ultrasound in Medicine & Biology 48 (2022): S40. http://dx.doi.org/10.1016/j.ultrasmedbio.2022.04.118.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Kramer, Neil, and Elliot D. Rosenstein. "Assessment and prognosis of rheumatoid arthritis Richard S. Panush, MD." Current Opinion in Rheumatology 4, no. 3 (June 1992): 355–64. http://dx.doi.org/10.1097/00002281-199206000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Herrlinger, J. D., and J. U. Asmussen. "Long term prognosis in yersinia arthritis: clinical and serological findings." Annals of the Rheumatic Diseases 51, no. 12 (December 1, 1992): 1332–34. http://dx.doi.org/10.1136/ard.51.12.1332.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Cen, Xiaomin, Min Yang, Geng Yin, and Qibing Xie. "Unfavorable Prognosis in a Patient With Neglected Juvenile Idiopathic Arthritis." Journal of Clinical Rheumatology 18, no. 7 (October 2012): 370–71. http://dx.doi.org/10.1097/rhu.0b013e31826d241b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

M. Feder, Henry, Micha Abeles, Megan Bernstein, Diane Whitaker-Worth, and Jane M. Grant-Kels. "Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis." Clinics in Dermatology 24, no. 6 (November 2006): 509–20. http://dx.doi.org/10.1016/j.clindermatol.2006.07.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Kanski, Jack J. "Uveitis in juvenile chronic arthritis: Incidence, clinical features and prognosis." Eye 2, no. 6 (November 1988): 641–45. http://dx.doi.org/10.1038/eye.1988.118.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Semenova, O. V., and S. O. Salugina. "Juvenile idiopathic arthritis outcome and prognosis according to catamnesis evaluation." Rheumatology Science and Practice, no. 5 (October 15, 2005): 71. http://dx.doi.org/10.14412/1995-4484-2005-48.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Lee, Jeong Heon, Sang Youn Jung, G. Kate Park, Kai Bao, Hoon Hyun, Georges El Fakhri, and Hak Soo Choi. "Fluorometric Imaging for Early Diagnosis and Prognosis of Rheumatoid Arthritis." Advanced Science 7, no. 1 (December 2019): 1902267. http://dx.doi.org/10.1002/advs.201902267.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Parvanescu, Cristina Dorina, Andreea Lili Barbulescu, Paulina Lucia Ciurea, Beatrice Andreea Chisalau, Sineta Cristina Firulescu, Adina Turcu Stiolica, Stefan Cristian Dinescu, et al. "Gout - Risks, Comorbidities and Associations." Revista de Chimie 70, no. 8 (September 15, 2019): 2948–53. http://dx.doi.org/10.37358/rc.19.8.7462.

Full text

Abstract:

Being the most common inflammatory arthritis, gout is highly associated to several comorbidities that have important consequences on patient�s prognosis and are related to a frequent premature mortality. The study aimed to analyse the type and frequency of gouty arthritis related comorbidities, by testing for correlations between plasma level of uric acid and a series of clinical features and laboratory markers associated with inflammatory status, metabolic abdormalities and systemic complications. After analysing the results, we noticed the presence of comorbidities in signficant percentages, directly correlated to serum uric acid levels. Our observations underline the necesity of a complex evaluation, in order to reveal even subclinical associated pathologies and prevent possible events, with an input on patients� prognosis.

APA, Harvard, Vancouver, ISO, and other styles

47

Omelchenko, V. O., M. A. Korolev, T. I. Pospelova, and V. I. Konenkov. "Cardiovascular risk in rheumatoid arthritis." Clinical Medicine (Russian Journal) 96, no. 6 (November 11, 2018): 491–97. http://dx.doi.org/10.18821/0023-2149-2018-96-6-491-497.

Full text

Abstract:

The problem of high mortality in patients with rheumatoid arthritis, one of the most common autoimmune diseases, is still unsolved. Many studies have shown a significant impact on cardiovascular risk of both traditional and non-traditional risk factors (genetic, RA-associated etc). To improve the individual prognosis, team actions by physicians of different specialties are necessary on the basis of good awareness and patients ’ compliance. The aim of the review was to characterize the main factors involved in the formation of cardiovascular risk and give a notion about the features of its assessing in patients with rheumatoid arthritis. Literature search was carried out using Scopus, Web of Science, RSCI by keywords.

APA, Harvard, Vancouver, ISO, and other styles

48

Huang, Kun, and Rohit Aggarwal. "Antisynthetase syndrome: A distinct disease spectrum." Journal of Scleroderma and Related Disorders 5, no. 3 (February 18, 2020): 178–91. http://dx.doi.org/10.1177/2397198320902667.

Full text

Abstract:

The discovery of novel autoantibodies related to idiopathic inflammatory myopathies (collectively referred to as myositis) has not only advanced our understanding of the clinical, serological, and pathological correlation in the disease spectrum but also played a role in guiding management and prognosis. One group of the myositis-specific autoantibodies is anti-aminoacyl-tRNA synthetase (anti-ARS or anti-synthetase) which defines a syndrome with predominant interstitial lung disease, arthritis, and myositis. Autoantibodies to eight aminoacyl-tRNA synthetases have been identified with anti-Jo1 the most common in all of idiopathic inflammatory myopathies. Disease presentation and prognosis vary depending on which anti-aminoacyl-tRNA synthetase antibody is present. In this review, we will discuss the clinical characteristics, overlap features with other autoimmune diseases, prognostic factors, and management of the antisynthetase syndrome.

APA, Harvard, Vancouver, ISO, and other styles

49

Ilchenko, Svitlana, Anastasiia Fialkovska, Svitlana Ivanus, and Tetiana Baralei. "A Rare Case of a Severe Course of Systemic Onset of Juvenile Idiopathic Arthritis Associated with MEFV Gene Mutations in a 12-year-old Girl." Journal of Rare Diseases and Orphan Drugs 2 (May 18, 2021): 24–29. http://dx.doi.org/10.36013/jrdod.v2i.61.

Full text

Abstract:

Juvenile idiopathic arthritis (JIA) is a common rheumatic disease in children and adolescents. MEFV (Mediterranean fever, FMF) gene mutations are observed in systemic-onset JIA, that in addition to increasing the risk of JIA development, worsen the disease prognosis. We reported a rare case of a severe systemic-onset JIA associated with MEFV gene mutations in a 12-year-old girl. The patient had an aggressive disease course and resistance to conventional immunosuppressive agents. This case confirms the difficulties of diagnostic and treatment of systemic JIA (sJIA) associated with FMF. Currently, there are no established criteria for the definition or differential diagnosis of arthritis associated with FMF. The severe prognosis of JIA associated with FMF should motivate clinicians to initiate aggressive therapy early.

APA, Harvard, Vancouver, ISO, and other styles

50

Kunnumpurath, Anthony, Sai Prasad Desikan, Charles McClain, and Raman Desikan. "Chronic Myelomonocytic Leukemia Presenting With Polyserositis and Seropositivity for Rheumatoid Arthritis." Journal of Investigative Medicine High Impact Case Reports 8 (January 2020): 232470962096686. http://dx.doi.org/10.1177/2324709620966863.

Full text

Abstract:

Chronic myelomonocytic leukemia (CMML) is a rare clonal stem cell disorder associated with clinical and pathologic of myelodysplasia and myeloproliferation. Systemic autoimmune/inflammatory disorders (SAID) and polyserositis have been associated with CMML. These manifestations can be observed concomitantly, shortly before diagnosis or anytime along the course of illness. We report a case of myeloproliferative CMML who presented with polyserositis and positive serology for rheumatoid arthritis. Retrospective studies of myelodysplasia/CMML have reported 15% to 25% incidence of SAID. The most commonly observed disorders include systemic vasculitis, connective tissue diseases, polychondritis, seronegative arthritis, and immune thrombocytopenia. SAID does not confer adverse prognosis in retrospective studies. Polyserositis is less common; this may result from leukemic infiltrate or result from autoimmunity. Treatment of serositis includes steroids and cytoreductive agents. Serositis may confer poor prognosis and hypomethylating therapy may improve the outcome.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!